Acetaminophen only

PreclinicalSmall molecule

TTaipei Medical University WanFang Hospital

Acetaminophen only is one of 11 small molecule programs targeting Radiculopathy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

RadiculopathyActive, not recruiting

RadiculopathyPreclinical

Active, not recruiting

Competition

Competitive Landscape

12 competitors in Radiculopathy

#DrugCompanyPhaseTrials

Epidiolex

Advil

1 3

Trental

VValidus Pharmaceuticals

Approved

1 4

Kenalog

BBausch Health Americas, Inc.

Approved

—5

Lyrica

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Kenalog

Marcaine

Catapres

1 9

Aristospan

EEthypharm

Preclinical

1 10

Lidocaine Hcl

MMayo Clinic

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Radiculopathy1 trial

Comparing Two Different Cervical Collars for the Treatment in Patient With Cervical Radiculopathy and Radicular Pain

Unknown status·TTaipei Medical University WanFang Hospital·N/A·NCT00880828·72 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Acetaminophen only. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Acetaminophen only compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Acetaminophen only. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Taipei Medical University WanFang Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTaipei Medical University WanFang Hospital

Acetaminophen only

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Radiculopathy1 trial

References

Drug Info

Quick Facts

Related News